ValiRx (LON:VAL) Issues Earnings Results

ValiRx (LON:VALGet Free Report) released its quarterly earnings results on Monday. The company reported GBX (0.22) earnings per share (EPS) for the quarter, Digital Look Earnings reports. ValiRx had a negative net margin of 20,554.01% and a negative return on equity of 55.84%.

ValiRx Price Performance

VAL stock opened at GBX 0.58 on Tuesday. The company has a market capitalization of £2.15 million, a P/E ratio of -39.66 and a beta of 0.59. The company has a debt-to-equity ratio of 0.44, a quick ratio of 1.27 and a current ratio of 6.65. ValiRx has a 52-week low of GBX 0.38 and a 52-week high of GBX 2.37. The business has a 50-day simple moving average of GBX 0.62 and a two-hundred day simple moving average of GBX 0.57.

About ValiRx

(Get Free Report)

ValiRx accelerates the development of treatments in cancer and women’s health to improve patient lives. We provide the scientific, financial and commercial framework to enable the rapid translation of innovative science into clinical development.

Read More

Earnings History for ValiRx (LON:VAL)

Receive News & Ratings for ValiRx Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ValiRx and related companies with MarketBeat.com's FREE daily email newsletter.